Traws Pharma, Inc.TRAWNASDAQ
Loading
Cash Flow Under PressureContracting
Percentile Rank29
Studio
Year-over-Year Change

Cash generated from core business operations

Latest
$-24.30M
↓ 14% vs avg
Percentile
P29
Within normal range
Streak
1 yr
Consecutive growthContracting
Average
$-21.40M
Historical baseline
PeriodValueYoY Change
TTM$-24.30M+18.4%
2024$-29.79M-66.1%
2023$-17.93M-10.1%
2022$-16.29M+16.4%
2021$-19.49M+15.5%
2020$-23.07M-10.8%
2019$-20.83M+8.2%
2018$-22.70M+4.7%
2017$-23.82M-50.6%
2016$-15.81M-